Spain – Pharmaceutical products – CBAM 494/2025 JANSSEN CILAG/07
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
PNAMSP 126/2025 FRAMEWORK AGREEMENT FOR A SINGLE COMPANY WHICH SET CONDITIONS FOR THE SUMMARY OF SUCCESSIVE TRACT AND UNIT PRICE OF THE EXCLUSIVE MEDICINAL PRODUCT CILTACABTAGEN AUTOLEUCEL 3.20MILL CELLS/INJECTABLE IV 30 ML-Capac:30; Pharmaceutical form INJECTABLE IV (COMMERCIAL NAME CARVYKTI 3.2×10 6-1×108 CELLS DISPERSION FOR PERFUSION), FOR HOSP.U.VIRG.ROCÍO, REINA SOFÍA AND REGIONAL, CENTERS ATTACHED TO CPC OF SEVILLA, CÓRDOBA AND MÁLAGA, THROUGH PROC.NEG.NON-PUBLIC.CON COMPANY JANSSEN-CILAG,SA, PROCESS URGENT